ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs MXN
16.78773
-0.78%
Brent Oil
83.95
0.47%
Bitcoin
62,961.62
2.90%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Innovation Pharmaceuticals Inc (CE) (IPIX)

  7. Innovation Pharmaceuticals Inc (CE) (IPIX) Noticias

IPIX

Innovation Pharmaceuticals (CE) (IPIX)

Innovation Pharmaceuticals Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:IPIX
FechaHoraFuenteTítuloSímboloCompañía
01/02/202407:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
20/11/202315:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/11/202307:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202308:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/05/202307:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/02/202306:31Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
04/01/202315:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202215:01Edgar (US Regulatory)Annual Report (10-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202211:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/07/202215:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/11/202109:20InvestorsHub NewsWireIQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should CloseUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
11/10/202106:00InvestorsHub NewsWireCEO Presenting on the Emerging Growth Conference on October 13 Register NowUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
29/09/202107:00InvestorsHub NewsWireCEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register NowUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202106:24InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% GrowthUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
21/07/202105:47InvestorsHub NewsWireNightfood, Inc. (OTCQB: NGTF) Significant Retail ExpansionUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/06/202106:00InvestorsHub NewsWireThe Emerging Growth Conference is Today.  Register Now.USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/03/202105:37InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company HistoryUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
11/02/202115:47Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/02/202105:48InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) Record January NET Revenue of $1.48 Million Beating TargetUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
02/02/202105:52InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) $17 million Sales, 60% Growth & 5 New ProductsUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
22/12/202007:05InvestorsHub NewsWireBiotech Companies; Recent Milestones and Potential UpsideUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/12/202005:03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/11/202005:48InvestorsHub NewsWireEpazz, Inc. (OTC Pink: EPAZ) Adds Vaccine Management as part of COVID Compliance FeaturesUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
20/07/202005:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/07/202016:09Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
16/04/202007:00InvestorsHub NewsWireCannabis and CBD Stocks are Old News, The Next Hot Peripheral Sector is Here!USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
26/12/201916:19Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
17/10/201916:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
13/08/201915:11Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
02/08/201915:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:IPIX

Su Consulta Reciente

CCOM
OILBRENT
Brent Oil
NYSE
JPM
JP Morgan Chase
USOTC
ADDYY
Adidas (QX)
AMEX
XLE
Energy Select Sector SPDR
NYSE
NKE
Nike
CCOM
US30
US 30
AMEX
XLF
Financial Select Sector
CCOM
SILVER
SILVER
PM
XAUUSD
Gold vs US Dollar
NASDAQ
MSFT
Microsoft
USOTC
DTEGY
Deutsche Telekom (QX)
USI
USTECH100
US Tech 100
COIN
SOLUSD
Solana
NASDAQ
NVDA
NVIDIA
CCOM
US500
US 500
NYSE
XOM
Exxon Mobil
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados